跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,389 条关于
“PST-611-CT1”
全部
26,389
临床试验
23,173
药物
2,074
机构
257
资讯
885
去年
PulseSight Therapeutics Doses First Patient in Phase I Trial of PST-611 for Dry AMD
去年
PulseSight Therapeutics Advances PST-611 for Dry AMD/Geographic Atrophy into Phase I Trial
去年
PulseSight Therapeutics Initiates Clinical Development of Novel Transferrin Therapy for Geographic Atrophy
去年
PulseSight Therapeutics to Present PST-611 Data for Dry AMD at EVER Congress 2024
去年
PulseSight Therapeutics Presents Promising Data on PST-611 for Dry AMD/Geographic Atrophy
7个月前
PulseSight Therapeutics Completes Phase I Dosing for Novel Gene Therapy PST-611 in Geographic Atrophy
去年
Landmark Study Confirms Liver Health Biomarker cT1 Predicts Cardiac and Liver Outcomes
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
6个月前
Piston Bio Secures FDA Alignment for First-in-Class Cancer-Related Apathy Treatment PST-101
3年前
Evolution of Axillary Management in Breast Cancer Therapy: A Focus on De-escalation and Escalation Strategies
第 1 页,共 89 页
上一页
下一页